Author

Timothy F. Campbell

University of California, Berkeley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Daniel A. PortnoyiD· 1 shared Diego Gonzalez Ventura· 1 shared Jenna VickeryiD· 1 shared Jesse Garcia CastilloiD· 1 shared Julia Ybarra· 1 shared Michel J.P. DuPageiD· 1 shared Nicole Flores Hernandez· 1 shared Sebastian Fernandez· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Daniel A. PortnoyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TLR2 signaling uniquely destabilizes tumor Tregs to promote cancer immunotherapy

Timothy F. Campbell, Jesse Garcia Castillo, Sebastian Fernandez, Diego Gonzalez Ventura, Jenna Vickery, Stefan Homentcovschi, Nicole Flores Hernandez, Julia Ybarra, Daniel A. Portnoy, Michel J.P. DuPage

This study shows that TLR2 signaling in innate immune cells within tumors reduces Treg stability, enhancing cancer immunotherapy by improving CD8+ T cell function.

bioRxiv · Jun 26, 2025 · PreprintImmunology